Panel Gives Green Light to Cannabidiol Drug

In an article published in Chemical & Engineering News, a strawberry-flavored oral solution containing cannabidiol (CBD) derived from cannabis plants is one step closer to being approved by the U.S. Food & Drug Administration for treating two rare forms of epilepsy in children. The drug would be the first of its kind to enter the U.S. market, opening the door to a new era of cannabis-derived medicines. Read the full article.